Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Inventory (2025)

BridgeBio Pharma's Inventory history spans 1 years, with the latest figure at $26.8 million for Q4 2025.

  • For Q4 2025, Inventory changed N/A year-over-year to $26.8 million; the TTM value through Dec 2025 reached $26.8 million, changed N/A, while the annual FY2025 figure was $26.8 million, N/A changed from the prior year.
  • Inventory for Q4 2025 was $26.8 million at BridgeBio Pharma, up from $24.5 million in the prior quarter.
  • Across five years, Inventory topped out at $26.8 million in Q4 2025 and bottomed at $4.0 million in Q1 2025.